CoreFirst Bank & Trust Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

CoreFirst Bank & Trust purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 100 shares of the biotechnology company’s stock, valued at approximately $59,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Prestige Wealth Management Group LLC boosted its holdings in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new position in Axon Enterprise during the fourth quarter worth approximately $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise during the third quarter worth $41,000. Y.D. More Investments Ltd purchased a new stake in Axon Enterprise in the 4th quarter valued at $45,000. Finally, Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter worth $53,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AXON has been the subject of a number of analyst reports. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Stock Up 0.8 %

Shares of NASDAQ:AXON opened at $577.18 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market capitalization of $44.23 billion, a PE ratio of 149.14, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm’s 50-day moving average is $591.92 and its two-hundred day moving average is $546.67. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Insiders Place Their Bets

In other news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.